![Greg Hurlbut](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Greg Hurlbut
Oprichter bij
SIONNA THERAPEUTICS, INC.
Profiel
Greg Hurlbut is the founder of Sionna Therapeutics, Inc. since 2019, holding the title of Senior Vice President-Discovery Research.
Former job includes Head-Protein Conformational Diseases at Genzyme Therapeutics Ltd. Education includes an undergraduate degree from the University of Massachusetts and a doctorate from Université Paris-Saclay.
Actieve functies van Greg Hurlbut
| Bedrijven | Functie | Begin |
|---|---|---|
| SIONNA THERAPEUTICS, INC. | Oprichter | 01-08-2019 |
Eerdere bekende functies van Greg Hurlbut
| Bedrijven | Functie | Einde |
|---|---|---|
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | - |
Opleiding van Greg Hurlbut
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
23
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sionna Therapeutics, Inc.
 Sionna Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for CF and rare diseases | Health Technology |
